BrightInsight Announces Partnershipwith Sanofi to Bring to Market aNext GenerationDigital Companion Application
CIOREVIEW >> Compliance >>

BrightInsight Announces Partnershipwith Sanofi to Bring to Market aNext GenerationDigital Companion Application

By CIOReview | Friday, April 1, 2022

BrightInsight’sPlatform has been selected to Accelerate Continuous Developmentof one of Sanofi’sBest-In-Class Software as a Medical Device

SAN JOSE, Calif.  – (Globe Newswire) BrightInsight, Inc., provider of the leading global platform for biopharma and medtech regulated digital health solutions, announced today a partnership with Sanofi, a global biopharmaceutical company focused on human health, to bring to market a next generation digital companion application for one of Sanofi’s products. The BrightInsight® Platform has beenselected to serve as the underlying infrastructure to accelerate continuous development of one of Sanofi’s best-in-class Software as a Medical Device.

Leveraging the BrightInsight® Platform, Sanofi’s digital companionapplication will provide easy access to patient services andsupport patients from therapy onboardingto chronic disease management with theaim to enhance patients’ healthcare experiencesand outcomes.The solution is comprised of a patient mobile app, which integrates with third-party systems for the creation of a connected ecosystem, andwill enable users to manage their complex conditions with custom profile and content, and step-by-step therapy administration guidance. The app will be available first in the U.S. and then launch across international markets.

“BrightInsight has a track record of partnering with innovative and forward-looking biopharma leaders like Sanofi, who understand the value created by regulated digital health solutionsthatsupport treatment,” said Kal Patel, MD, CEO & Co-Founder, BrightInsight. “Our deep experience launching Software as a Medical Device, regulatory expertise and robust platform enable us to support Sanofi’s goals of accelerating time to market and delivering an exceptional patient experience in a manner compliant to the various critical and complex regulatory, quality, privacy and security requirements.”

Emmanuel Frenehard, Global Head of Digitalat Sanofi, indicated that BrightInsight was selected to help Sanofi build and launch Sanofi’s latest Software as a Medical Device, providing a disease management solution for one of its most important treatments.The partnership supportsSanofi’s digital strategy to create more engaging patient experienceswith the goal to improve treatment outcomes.